Article
Anti-inflammatory chemoprevention attenuates the phenotype in a mouse model of esophageal adenocarcinoma.
Carcinogenesis - 19 Aug 2021
Baumeister Theresa, Ingermann Jonas, Marcazzan Sabrina, Fang Hsin-Yu, Oellinger Rupert, Rad Roland, Engleitner Thomas, Kleigrewe Karin, Anand Akanksha, Strangmann Julia, Schmid Roland M, Wang Timothy C, Quante Michael
Abstract excerpt
Barrett's esophagus (BE) is the main known precursor condition of esophageal adenocarcinoma (EAC). BE is defined by the presence of metaplasia above the normal squamous columnar junction and has mainly been attributed to gastroesophageal reflux disease and chronic reflux esophagitis. Thus, the rising incidence of EAC in the Western world is probably mediated by chronic esophageal inflammation, secondary to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
